oral dose of semaglutide for weight loss Dosage Chart & Dosing Guide Oral Semaglutide Dose-Response Curve: Weight

There are still substantial clinical challenges in treating patients who come with type 2 diabetes and/or obesity in addition to chronic kidney disease (CKD)

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

Mechanisms underlying long-term sustained weight loss and glycemic normalization after obesity surgery include changes in gut hormone levels, including glucagon-like peptide 1 (GLP-1) and peptide YY (PYY)

According to new research, semaglutide (sold as Ozempic for diabetes and Wegovy for obesity) may also help curb alcohol intake

503B outsourcing facilities must cease compounding, distributing, or dispensing by May 22, 2025